Nortriptyline and Interpersonal Psychotherapy as Maintenance Therapies for Recurrent Major Depression: A Randomized Controlled Trial in Patients Older Than 59 Years

Article Abstract:

Combination treatment with nortriptyline and interpersonal psychotherapy (IPT) appears to be effective in preventing a recurrence of depression in elderly patients. Researchers randomly assigned 187 who had been successfully treated for depression to one of four groups: nortriptyline alone, nortriptyline plus IPT, IPT alone, or a placebo. Both nortriptyline alone and IPT alone were more effective than a placebo in preventing a recurrence of depression. The combination of nortriptyline and ITP was more effective than either one alone.

Psychological aspects, Aged, Elderly, Evaluation, Prevention, Depression, Mental, Depression (Mood disorder), Nortriptyline

---

Maintenance treatment of major depression in old age

Article Abstract:

The efficacy of maintenance paroxetine and monthly interpersonal psychotherapy in elderly patients with major depression, including those having a first episode, is assessed. The evaluation of both pharmacologic and psychotherapeutic strategies has shown that two years of maintenance with paroxetine is effective.

England, Usage, Comparative analysis, Depression in old age, Geriatric depression, Paroxetine

---

Treatment of complicated grief: A randomized controlled trial

Article Abstract:

The efficacy of a novel approach, complicated grief treatment with a standard psychotherapy is compared. The results reveal that complicated grief treatment is an improved treatment over interpersonal psychotherapy, showing higher response rates and faster time to response.

Health aspects, Grief

Similar abstracts:

• Abstracts: Effect of maintenance therapy with varenicline on smoking cessation: A randomized controlled trial
• Abstracts: Effect of vitamin E and beta carotene on the incidence of angina pectoris: a randomized, double-blind, controlled trial
• Abstracts: Interpersonal communication. The personal touch: How technology can strengthen the bonds between patients, professionals
• Abstracts: Implications of halted study's finding's for hypertension guidelines unclear
• Abstracts: The price of sight - Ranibizumab, Bevacizumab, and the treatment of macular degeneration. Commercial support and continuing medical education

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.